Search

Your search keyword '"Advaxis Inc. -- Intellectual property"' showing total 4 results
Start Over Descriptor "Advaxis Inc. -- Intellectual property" Journal vaccine weekly
4 results on '"Advaxis Inc. -- Intellectual property"'

1. 'Immunogenic Compositions Targeting Recurrent Cancer Mutations And Methods Of Use Thereof' in Patent Application Approval Process (USPTO 20240124540)

Subjects
Advaxis Inc. -- Intellectual property, Diseases -- Relapse, Biotechnology industry -- Intellectual property, Vaccines -- Intellectual property -- Methods, Health
Abstract

2024 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent application by the inventors Balli, David (Warrington, PA, US); Coder, Brandon (Trenton, NJ, [...]

Published
2024

2. Patent Issued for Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof (USPTO 11897927)

Subjects
Advaxis Inc. -- Intellectual property, Listeria -- Methods, Diseases -- Relapse, Biotechnology industry -- Intellectual property, Amino acids -- Intellectual property -- Methods -- Genetic aspects, Vaccines -- Intellectual property -- Methods, Health
Abstract

2024 MAR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Advaxis Inc. (Princeton, New Jersey, United States) has been issued patent number 11897927, according to [...]

Published
2024

3. 'Immunogenic Heteroclitic Peptides From Cancer-Associated Proteins And Methods Of Use Thereof' in Patent Application Approval Process (USPTO 20210177955)

Subjects
Advaxis Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Amino acids -- Methods -- Intellectual property, Cancer -- Methods, Vaccines -- Intellectual property -- Methods, Peptides -- Methods, Health
Abstract

2021 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent application by the inventors BALLI, David (Warrington, PA, US); CODER, Brandon (Trenton, NJ, [...]

Published
2021

4. USPTO Grants Advaxis New Listeria Based Fusion Protein Patent

Subjects
Advaxis Inc. -- Intellectual property, Biological products, Biotechnology industry -- Intellectual property, Immunotherapy, Drugs, Cancer, Proteins, Patents, Patent/copyright issue, Health
Abstract

The US Patent and Trademark Office (USPTO) has issued Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, patent #7662396 titled 'Compositions and Methods for Enhancing the [...]

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results